Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 23, 1997
Kappa2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victimsJ K Staley, R B Rothman, K C Rice, et al.
European Journal of Pharmacology|February 10, 1998
Pharmacological characterization of the vesamicol analogue (+)-[(125)I]MIBT in primate brainJ K Staley, D C Mash, S M Parsons, et al.
Life Sciences|January 1, 1995
Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotoninD C Mash, J K Staley, M H Baumann, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victimsJ K Staley, W L Hearn, A J Ruttenber, et al.
Neurobiology of Aging|July 1, 1997
Vesicular acetylcholine transporter density and Alzheimer's diseaseS M Efange, E M Garland, J K Staley, et al.
Neuroreport|January 31, 1996
Altered dopamine transporter densities in alcohol-preferring vervet monkeysD C Mash, J K Staley, F M Doepel, et al.
Neuroscience Letters|June 2, 1995
Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complexD C Mash, J K Staley, J P Pablo, et al.
The American Journal of Psychiatry|September 29, 2000
Prediction of dopamine transporter binding availability by genotype: a preliminary reportL K Jacobsen, J K Staley, S S Zoghbi, et al.
The American Journal of Psychiatry|June 30, 2000
Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patientsL K Jacobsen, J K Staley, R T Malison, et al.
Annals of Neurology|April 1, 1997
Immunochemical analysis of dopamine transporter protein in Parkinson's diseaseG W Miller, J K Staley, C J Heilman, et al.
Pageof 3